Robyn Denholm sold Tesla stock in recent months while Elon Musk, the chief executive she oversees, worked for President Trump ...

Traditionally, the stock has exhibited a slightly greater likelihood of negative one-day returns following earnings reports.

Pakistan ceasefire, Indian defence companies have seized the opportunity to showcase their products on the global stage, ...

With the stock's current price at Rs 1832.00, Bharti Airtel's performance will be closely watched by investors, especially in ...

With Sun Pharmaceutical Industries’ last traded price at Rs 1700.00, the stock reflects ongoing market dynamics and investor ...

Welcome to the Britannia Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

Return on Assets (ROA): Myriad Genetics's financial strength is reflected in its exceptional ROA, which exceeds industry ...

Much to the surprise of many on Wall Street, the S&P 500 has managed to erase all of its losses from earlier in the year, and ...

Ahead of the forthcoming earnings, consensus estimates forecast earnings per share (EPS) of $0.17 on revenue of $201 million.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $88.4, a ...

The WTR Brand Elite index fell six points to 151 across February and March, as industry braced itself for the full impact of US tariffs. Register for free to receive our newsletter, view leading ...

This momentum model looks for stocks with strong and consistent intermediate-term relative performance. HIMS & HERS HEALTH INC (HIMS) is a mid-cap growth stock in the Biotechnology & Drugs industry.